Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit der Wirkstoffkombination aus Drospirenon und Ethinylestradiol (ATC-Code: G03AA12).

Conclusion of a non-exclusive rebate contract pursuant to Section 130a (8) SGB V for medicinal products with the active substance combination of drospirenone and ethinylestradiol (ATC Code: G03AA12) within the period from 01.11.2026 to 31.10.2028 with the possibility of concluding the contract at any time during the contract period ("open-house model").